Bovine TB

With permission, Mr. Speaker, I wish to make a statement about the Government's plans for tackling bovine TB in England. In doing so, I would like to thank the Select Committee on Environment, Food and Rural Affairs both for its comprehensive and thoughtful report and for allowing me additional time to respond to it, which I have now done. I am also grateful to Professor Bourne and the members of the Independent Scientific Group for their thorough scientific study. Bovine TB is not a new problem. For more than 70 years, successive Governments have implemented cattle controls based on surveillance, testing and the slaughter of reactors. Those have been designed to protect public health, reduce the economic impact of the disease on farmers and, more recently, to comply with our obligations under European legislation. By the mid-1970s, the incidence of TB in cattle had reached an all-time low. However, since the 1980s, disease incidence has increased again—with a significant rise following the 2001 foot and mouth epidemic—and last year, nearly 3,200 new TB incidents were recorded and 18,543 reactor cattle were slaughtered in England. Bovine TB is a serious problem, particularly in the south-west and the midlands. Although more than 90 per cent. of herds are TB free at any one time and some significant cattle farming areas are largely without the disease, I know from listening to farmers living with it just how difficult it is, and for those most seriously affected, I know that the economic and human consequences are simply devastating. That is why we should take the right decisions to help. Bovine TB is transmitted between cattle, and between cattle and badgers, but what has dominated the debate is whether badger culling could be effective in controlling the disease. The 10-year randomised badger culling trial overseen by the Independent Scientific Group on cattle TB, culled some 11,000 badgers to discover what impact it would have. The ISG's final report, published last year, concluded that reactive culling—killing badgers in areas where there had been local TB breakdowns—made the problem worse; and that proactive culling, which involves taking an area of about 100 sq km and repeatedly culling badgers over a number of years, produced only marginal benefits because although TB was reduced in that area, it increased outside of it because of the disturbance and movement of badgers. While scientists agree that a prolonged and effective cull over even larger areas—some 250 to 300 sq km—could reduce the incidence of bovine TB, the ISG's judgment was that the practicality and cost of delivering a cull on that scale meant that"““badger culling cannot meaningfully contribute to the future control of cattle TB””." Having listened carefully to a wide range of views from scientists, farming, veterinary and wildlife organisations, and many others, and having considered all the evidence, I have decided that although such a cull might work, it might also not work. It could end up making the disease worse if the cull was not sustained over time or delivered effectively, and public opposition, including the unwillingness of some landowners to take part, would render that more difficult. It would not be right to take that risk. Therefore, in line with the advice that I have received from the Independent Scientific Group, our policy will be not to issue any licences to farmers to cull badgers for TB control, although we remain open to the possibility of revisiting that policy under exceptional circumstances, or if new scientific evidence were to become available. This has been a difficult decision to take, and I know that farmers affected will be disappointed and angry. We all want the same thing—to beat this terrible disease—but I have had to reach a view about what will be effective in doing so, guided by the science and the practicality of delivering a cull. Having made a commitment to farmers and others that I would take a decision, now that it has been made, we need to put all our efforts into working together to take action that can work in all affected areas. I have therefore also decided to make vaccination a priority, as recommended by the Select Committee. Effective vaccines could in future provide a viable way of tackling disease in both badgers and cattle. We have invested £18 million in the past 10 years in vaccine development, which has delivered good results, including: evidence that vaccinating young calves is effective; making progress towards developing a test to distinguish between infected and vaccinated cattle; showing that injectable BCG can protect badgers; and developing oral badger vaccine baits. I now intend to increase significantly our spending on vaccines by putting in £20 million over the next three years to strengthen our chances of successfully developing them. I will also provide additional funding to set up and run a practical project to prepare for deploying vaccines in future. It could be some time before an oral vaccine for badgers, or a cattle vaccine, becomes available, so for now we must reduce the spread of the disease, and try to stop it becoming established in new areas. We have cattle controls in place to tackle TB, and have strengthened them in recent years with the introduction of pre-movement testing and the targeted use of the more sensitive gamma interferon test. But the action that individual farmers take, in particular to deal with the risk of importing disease into their herd, will also remain critical. Disease control is not just a matter for Government, notwithstanding the considerable cost. Farmers have the main interest—the burden of controls falls most heavily on them—and they must be involved in working out how we go forward. It would be possible to tighten cattle measures still further as recommended by the ISG report, but that would come at a high cost. Whether it would be worthwhile is as much, if not more, a question for the industry as it is for Government. There is a choice to be made. That is why I have decided to set up a bovine TB partnership group with the industry to develop a joint plan for tackling bovine TB. We will discuss with the industry who should be on the group and how it should work, and I want to get started as quickly as possible. The group will have full access to information on the TB budget and will be able to make recommendations about its use. It will be able to propose further practical steps to tackle the disease, including, for example, whether there should be tighter cattle controls. It will help to reach decisions about the injectable vaccines deployment project. It will be able to look at ways of helping farmers to manage the impact of living under disease restrictions, for example by providing incentives for biosecurity, or maximising the opportunities to market their cattle by looking again at the restrictions around red markets and encouraging the establishment of more exempt and approved finishing units. I am prepared to make additional funding available to support such initiatives if the group makes a strong case for doing so. The House is united in its determination to overcome bovine TB, and much as we would all wish it, there is no quick or easy way of doing so. But our best chance is to work together, and I therefore hope that the industry will respond to my proposals so that we can get on with it.